JournalsHub
.online
Find My Journal
WX

Weichun Xu

Janssen (United States) US

38
Publications
3,513
Citations
22
H-Index
27
i10-Index
7.0
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. OA
Gary S. Hoffman, María C. Cid, Karen E. Rendt-Zagar, Peter A. Merkel, Cornelia M. Weyand +5 more
PubMed 2007
557
A Comparison of Clozapine and Haloperidol in Hospitalized Patients with Refractory Schizophrenia OA
Robert A. Rosenheck, Joyce A. Cramer, Weichun Xu, Jonathan Thomas, William Henderson +3 more
New England Journal of Medicine 1997
519
Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis OA
Désirée van der Heijde, Robert Landewé, Xenofon Baraliakos, Harry Houben, Astrid van Tubergen +5 more
Arthritis & Rheumatism 2008
517
Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate‐naive patients with active rheumatoid arthritis: Twenty‐four–week results of a phase III, multicenter, randomized, double‐blind, placebo‐controlled study of golimumab before methotrexate as first‐line therapy for early‐onset rheumatoid arthritis OA
Paul Emery, Roy Fleischmann, Larry W. Moreland, Elizabeth C. Hsia, Ingrid Strusberg +10 more
Arthritis & Rheumatism 2009
395
Golimumab in psoriatic arthritis: One‐year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo‐controlled trial OA
Arthur Kavanaugh, Désirée van der Heijde, Iain B. McInnes, Philip J. Mease, Gerald G. Krueger +11 more
Arthritis & Rheumatism 2012
209

Publications

38 total

Golimumab in psoriatic arthritis: One‐year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo‐controlled trial PDF

Arthur Kavanaugh, Désirée van der Heijde, Iain B. McInnes, Philip J. Mease, Gerald G. Krueger et al. - Arthritis & Rheumatism, 2012
Cited by 209 OpenAlex

Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study PDF

Arthur Kavanaugh, Iain B. McInnes, Philip J. Mease, Gerald G. Krueger, Dafna D. Gladman et al. - Annals of the Rheumatic Diseases, 2012
Cited by 91 OpenAlex

The effects of golimumab on radiographic progression in rheumatoid arthritis: Results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy

Paul Emery, Roy Fleischmann, Désirée van der Heijde, Edward Keystone, Mark C. Genovese et al. - Arthritis & Rheumatism, 2011
Cited by 115 OpenAlex

Significant improvement in synovitis, osteitis, and bone erosion following golimumab and methotrexate combination therapy as compared with methotrexate alone: A magnetic resonance imaging study of 318 methotrexate-naive rheumatoid arthritis patients

Mikkel Østergaard, Paul Emery, Philip G. Conaghan, Roy Fleischmann, Elizabeth C. Hsia et al. - Arthritis & Rheumatism, 2011
Cited by 92 OpenAlex

Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study PDF

Jürgen Braun, Xenofon Baraliakos, Kay‐Geert Hermann, Désirée van der Heijde, Robert D. Inman et al. - Annals of the Rheumatic Diseases, 2011
Cited by 83 OpenAlex

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate‐naive patients with active rheumatoid arthritis: Twenty‐four–week results of a phase III, multicenter, randomized, double‐blind, placebo‐controlled study of golimumab before methotrexate as first‐line therapy for early‐onset rheumatoid arthritis PDF

Paul Emery, Roy Fleischmann, Larry W. Moreland, Elizabeth C. Hsia, Ingrid Strusberg et al. - Arthritis & Rheumatism, 2009
Cited by 395 OpenAlex

Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis PDF

Désirée van der Heijde, Robert Landewé, Xenofon Baraliakos, Harry Houben, Astrid van Tubergen et al. - Arthritis & Rheumatism, 2008
Cited by 517 OpenAlex

Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two‐year period

Jürgen Braun, Atul Deodhar, Ben A. C. Dijkmans, Piet Geusens, Joachim Sieper et al. - Arthritis Care & Research, 2008
Cited by 106 OpenAlex

Population Pharmacokinetics of Infliximab in Patients With Ankylosing Spondylitis

Zhenhua Xu, Kathleen Seitz, Adedigbo A. Fasanmade, Joyce Ford, Paul Williamson et al. - The Journal of Clinical Pharmacology, 2008
Cited by 106 OpenAlex

Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. PDF

Gary S. Hoffman, María C. Cid, Karen E. Rendt-Zagar, Peter A. Merkel, Cornelia M. Weyand et al. - PubMed, 2007
Cited by 557 OpenAlex

Research Topics

Rheumatoid Arthritis Research and Therapies (16) Spondyloarthritis Studies and Treatments (13) Schizophrenia research and treatment (5) Autoimmune and Inflammatory Disorders Research (5) Prostate Cancer Treatment and Research (4)

Frequent Co-Authors

DÉ
Désirée van der Heijde
6 joint publications
MA
Mahboob U. Rahman
5 joint publications
SU
Sudha Visvanathan
3 joint publications
JO
Joyce A. Cramer
3 joint publications
DE
Dennis S. Charney
3 joint publications
PA
Paul Williamson
3 joint publications

Affiliations

Boston University
US 2007 - 2007
Cleveland Clinic
US 2007 - 2007
Janssen (Belgium)
BE 2017 - 2012
Johns Hopkins University
US 2007 - 2007
Emory University
US 2007 - 2007

External Profiles

OpenAlex Profile Search Semantic Scholar Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now